Target intelligence / Profile preview

Integrin beta 1 binding protein 1 pseudogene (None standardized; sometimes referenced as ITGB1BP1P or ITGB1P1, but no universal canonical abbreviation)

Target: None standardized; sometimes referenced as ITGB1BP1P or ITGB1P1, but no universal canonical abbreviation
Molecular classification: Other (pseudogene)

Overview

Integrin beta 1 binding protein 1 pseudogene (ENSG00000226814, LOC100130137) is a human pseudogene similar to the functional ITGB1BP1 gene, which encodes integrin beta-1 binding protein 1[3][5][2]. As a pseudogene, it does not encode a functional protein and has no characterized biological activity, disease association, or role in drug action. Its presence in databases is for genomic reference and does not indicate therapeutic or diagnostic utility. The functional ITGB1BP1 protein regulates integrin-dependent cell adhesion and cell-matrix interactions[6], but this pseudogene is noncoding and nonfunctional. Thus, it should not be considered a therapeutic target[3][5][2].

Other names: integrin beta 1 binding protein 1 pseudogeneLOC100130137pseudogene similar to integrin beta 1 binding protein 1ITGB1BP1PITGB1P1

Mechanism of action

None, as no drugs or ligands act on this locus.

Biological functions

None established; pseudogenes typically do not encode functional proteins.The parent gene ITGB1BP1 regulates integrin-mediated cell adhesion, but the pseudogene itself is considered noncoding and nonfunctional.

Disease associations

None confirmed.The parent protein is associated with cerebral cavernous malformations and immunodeficiency, but as a pseudogene, ENSG00000226814 has no documented disease role.

Safety considerations

None; pseudogenes are generally not involved in adverse effects or therapeutic challenges.

Interacting drugs

None. There are no drugs known to interact with this pseudogene.

Biomarkers

None established for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on Integrin beta 1 binding protein 1 pseudogene (None standardized; sometimes referenced as ITGB1BP1P or ITGB1P1, but no universal canonical abbreviation).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integrin beta 1 binding protein 1 pseudogene (None standardized; sometimes referenced as ITGB1BP1P or ITGB1P1, but no universal canonical abbreviation).

Explore the full profile